uBiome, Inc. Company Profile

23:44 EDT 21st September 2018 | BioPortfolio

Founded in 2012, uBiome is the leader in microbial genomics. The Company’s mission is to advance the science of the microbiome and make it useful to people. uBiome’s commercial products include SmartGut™, the world’s first sequencing-based clinical microbiome test, which identifies microbes in the gut for patients with chronic gut conditions such as IBD, IBS, Crohn’s Disease, and ulcerative colitis; SmartJane™, the first sequencing-based women’s health screening test, which genotypes all 19 clinically relevant strains of HPV, identifies four common STDs, and surveys more than 20 vaginal microbes associated with bacterial vaginosis and other conditions; and Explorer™, a health and wellness product to understand the role that food and lifestyle can play in wellness. uBiome’s platform has been used by hundreds of thousands of consumers, patients, and doctors and more than 200 research institutions around the world, including the US Centers for Disease Control (CDC), US National Institutes of Health (NIH), Harvard University, Stanford University, the Massachusetts Institute of Technology (MIT), University of California, San Francisco, Oxford University, and the University of Sydney. Since its launch, the company has received widespread recognition including CNN 10: Startups to Watch, the IVY Technology Award, CNN Future 30, and was named one of Fast Company’s Most Innovative Companies in Healthcare in 2016 and in Data Science in 2018, as well as a Technology Pioneer from the World Economic Forum in 2018. For more information, visit

News Articles [25 Associated News Articles listed on BioPortfolio]

Biotech Startup uBiome Raises $83M to Expand World’s Largest Human Microbiome Database

uBiome, a microbial genetics company leveraging artificial intelligence to develop wellness products, clinical tests, and therapeutics based on the microbiome, today announced it has raised $83 millio...

Microbiome Startup uBiome Expands into Drug Research with $83M

Biotech company uBiome started as a “citizen science” project that collected and studied microbiome samples in order to learn how the trillions of bacteria living in and on people’s bodies affec...

Bay Area’s uBiome Secures $83 Million as It Moves into Drug Development, Taps ex-Novartis CEO for...

San Francisco-based uBiome snagged $83 million in a Series C financing round and also tapped industry veteran Joe Jimenez, the former chief executive officer of Swiss pharma giant Novartis, to its boa...

uBiome Appoints Nutrition Expert, Danielle Capalino, MSPH, RD to its Scientific Advisory Board

Manhattan-based Registered Dietitian, Danielle Capalino, MSPH, RD, brings her expertise in digestive health to the uBiome board. SAN FRANCISCO (PRWEB) April 27, 2018 uBiome, the world’s leading mic...

uBiome, Leader in Microbial Genomics, Named One of the Most Innovative Companies of 2018 by Fast Company

uBiome, the leader in microbial genomics, has been named one of the most innovative companies of 2018 in the data science sector. SAN FRANCISCO (PRWEB) March 13, 2018 uBiome, the leader in microbial ...

uBiome moving into therapeutics with $83M series C

Brigham Young University Professors Publish Microbiome Study Results, Showing uBiome Explorer™ Kits Enhance Student Engagement in Undergraduate Science Courses

In a study recently published by the prestigious peer-reviewed scientific journal, PLOS ONE, a group of Brigham Young University professors set out to test if student engagement in scientific courses ...

uBiome Sponsors Annual Fundraising Walk, SF Take Steps, to Support the Crohn’s and Colitis Foundation

On May 5th, uBiome, the leader in microbial genomics, will be sponsoring SF Take Steps, hosted by the Northern California Chapter of the Crohn’s and Colitis Foundation, for the second consecutive ye...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Silver Diamine Fluoride and Gingivitis in Geriatric Patients

Gingivitis in the geriatric population is one of the growing global public health concerns, thus finding the most effective and non-invasive approach to prevent and treat gingivitis in the...

Companies [1 Associated Companies listed on BioPortfolio]

uBiome, Inc.

Founded in 2012, uBiome is the leader in microbial genomics. The Company’s mission is to advance the science of the microbiome and make it useful to people. uBiome’s com...

More Information about "uBiome, Inc." on BioPortfolio

We have published hundreds of uBiome, Inc. news stories on BioPortfolio along with dozens of uBiome, Inc. Clinical Trials and PubMed Articles about uBiome, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of uBiome, Inc. Companies in our database. You can also find out about relevant uBiome, Inc. Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record